Scholarlink

Background <p>Percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease is associated with increased anatomical complexity and adverse cardiovascular outcomes. Conventional angiography provides limited assessment of vessel structure and plaque characteristics, whereas intravascular imaging with intravascular ultrasound (IVUS) or optical coherence tomography (OCT) may improve procedural guidance. However, the clinical impact of imaging-guided PCI in this population remains uncertain.</p> Methods <p>We conducted a systematic review and meta-analysis of randomized controlled trials comparing intravascular imaging-guided versus angiography-guided PCI in patients with multivessel coronary artery disease regarding major adverse cardiovascular events (MACE). Major databases were searched through December 2025. Outcomes were pooled as risk ratios (RRs) with 95% confidence intervals (CIs) using random-effects models. Trial sequential analysis (TSA) and an exploratory network meta-analysis (NMA) were performed.</p> Results <p>Five randomized trials, including 3,023 patients, were analyzed. Imaging-guided PCI was associated with a significant reduction in MACE compared with angiography-guided PCI (RR 0.58, 95% CI 0.46 to 0.74; <i>p</i> &lt; 0.0001; I<sup>2</sup> = 9.8%). In subgroup analyses by imaging modality, IVUS-guided PCI was associated with a reduction in MACE (RR 0.53, 95% CI 0.39 to 0.73; <i>p</i> &lt; 0.0001; I<sup>2</sup> = 0%), as was OCT-guided PCI (RR 0.49, 95% CI 0.28 to 0.87; <i>p</i> = 0.014; I<sup>2</sup> = 24.3%). TSA provided supportive evidence for a beneficial effect of imaging-guided PCI. NMA suggested that both IVUS and OCT were associated with improved outcomes compared with angiography, with no significant difference between the two imaging modalities.</p> Conclusion <p>Intravascular imaging-guided PCI is associated with a reduction in MACE in patients with multivessel coronary artery disease. These findings support the clinical value of intravascular imaging in this population, with similar effects observed across imaging modalities.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Intravascular imaging-guided versus angiography-guided percutaneous coronary intervention in multivessel coronary artery disease: a systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月15日

查看全文
  • Ahmed Adel Mohamed,
  • Asmaa Magdy Elhefnawy,
  • Abdalrahman Salah Shehata,
  • Sara Khalid,
  • Abdelrahman Mostafa,
  • Abdullah Ali,
  • Baher Ibrahim,
  • Tasneem Zanati Saeed,
  • Mohammed Dibas

摘要

Background

Percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease is associated with increased anatomical complexity and adverse cardiovascular outcomes. Conventional angiography provides limited assessment of vessel structure and plaque characteristics, whereas intravascular imaging with intravascular ultrasound (IVUS) or optical coherence tomography (OCT) may improve procedural guidance. However, the clinical impact of imaging-guided PCI in this population remains uncertain.

Methods

We conducted a systematic review and meta-analysis of randomized controlled trials comparing intravascular imaging-guided versus angiography-guided PCI in patients with multivessel coronary artery disease regarding major adverse cardiovascular events (MACE). Major databases were searched through December 2025. Outcomes were pooled as risk ratios (RRs) with 95% confidence intervals (CIs) using random-effects models. Trial sequential analysis (TSA) and an exploratory network meta-analysis (NMA) were performed.

Results

Five randomized trials, including 3,023 patients, were analyzed. Imaging-guided PCI was associated with a significant reduction in MACE compared with angiography-guided PCI (RR 0.58, 95% CI 0.46 to 0.74; p < 0.0001; I2 = 9.8%). In subgroup analyses by imaging modality, IVUS-guided PCI was associated with a reduction in MACE (RR 0.53, 95% CI 0.39 to 0.73; p < 0.0001; I2 = 0%), as was OCT-guided PCI (RR 0.49, 95% CI 0.28 to 0.87; p = 0.014; I2 = 24.3%). TSA provided supportive evidence for a beneficial effect of imaging-guided PCI. NMA suggested that both IVUS and OCT were associated with improved outcomes compared with angiography, with no significant difference between the two imaging modalities.

Conclusion

Intravascular imaging-guided PCI is associated with a reduction in MACE in patients with multivessel coronary artery disease. These findings support the clinical value of intravascular imaging in this population, with similar effects observed across imaging modalities.